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Summary
Background:  The  aim  of  this  study  is  to  compare  the  periods  before  and  after  the
intervention  applied  using  the  ATC/DDD  method  in  order  to  ascertain  the  rational
use  of  antibiotics  in  a newly  established  hospital.
Method:  The  appropriateness  of  the  hospital’s  antibiotic  use,  consumption  rates  and
the  costs  were  calculated  and  compared  with  other  hospitals.  Based  on  these  data,
an  intervention  has  been  planned  in  order  to  raise  the  quality  of  antibiotic  use.  The
periods  before  and  after  the  intervention  were  compared.  Between  16  May  2011  and
23  May  2012,  data  were  collected  from  all  hospital  units  by  the  infectious  diseases
specialists  and  a  point  prevalence  survey  was  conducted.  Anatomical  therapeutic
chemical  classiﬁcation  and  the  deﬁned  daily  dose  (DDD)  methodology  were  used  to
calculate  the  antibiotic  consumption.
Results:  On  two  speciﬁc  days  in  2011  and  2012,  194  out  of  307  patients  (63.2%)
and  224  out  of  412  patients  (54.4%)  received  antibiotic  treatment,  respectively.  In
2011  and  2012,  the  percentage  of  appropriate  antibiotic  use  was  51%  and  64.3%,
respectively.  Both  in  2011  and  2012,  inappropriate  antibiotic  use  was  found  to  be
signiﬁcantly  higher  in  surgical  clinics  in  comparison  to  the  internal  diseases  clin-
ics  and  the  ICU.  This  was  caused  by  the  high  rates  of  inappropriate  perioperative
antimicrobial  prophylaxis  observed  in  surgical  clinics.  During  both  years,  approxi-
mately  one-third  of  the  antibiotics  were  prescribed  for  the  purposes  of  perioperative
prophylaxis,  while  88.5%  and  43.7%  of  these,  respectively,  were  inappropriate
and  unnecessary.  Cephalosporins,  ﬂuoroquinolones,  combinations  of  penicillins
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(WHO,  2009  [14]).
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Introduction
The  overuse  of  antimicrobial  agents  is  a global
problem. Several  studies  have  demonstrated  an
overall increase  in  the  rate  of  antimicrobial  drug
consumption  over  time.  This  widespread  use  of
antimicrobial  agents  has  been  associated  with
increased  healthcare  costs  and  the  emergence
of bacterial  resistance  to  these  drugs  [1—3].
Antibiotics are  among  the  drugs  associated  with
the highest  costs  worldwide  and  account  for
20—30% of  total  drug  expenditures  [4,5].  The  total
expenditure  on  antimicrobials  in  Turkey  in  2010
equaled  13.9%  of  all  drug  costs  and  ranked  ﬁrst
in drug  expenditures  [5]. However,  the  major-
ity of  this  consumption  is  considered  to  be
unnecessary or  inappropriate.  Inappropriate  antibi-
otic use  is  regarded  as  a  common  problem  in
Turkey [6].
Through rational  antimicrobial  use,  healthcare
costs can  be  reduced,  and  the  quality  of  antimi-
crobial treatment  can  be  improved.  According  to
reports,  20—50%  of  antimicrobial  use  in  hospitals
is questionable  or  inappropriate  [1,3].  These  data
highlight  the  importance  of  surveillance  of  antimi-
crobial  use.  To  improve  the  quality  of  antimicrobial
treatment and  to  reduce  the  related  costs,  sev-
eral recent  initiatives  have  encouraged  hospitals  to
undertake  surveillance  of  antimicrobial  consump-
tion patterns  to  evaluate  the  current  situation
[3,7].
Our  aim  was  to  compare  antibiotic  consump-
tion rates,  related  costs  and  the  appropriateness
of antibiotic  use  between  our  hospital  and  national
and international  hospitals.  In  particular,  the
Anatomical  Therapeutic  Chemical/Deﬁned  Daily
Dose (ATC/DDD)  method  was  used  to  ascertain
rational antibiotic  use  in  a  newly  established  hos-
pital. We  further  aimed  to  compare  the  periods
before and  after  an  intervention  planned  to
improve the  quality  of  antibiotic  use.
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bitors)  and  carbapenems  were  the  most  frequently
g  the  study  periods.  The  mean  total  antibiotic  con-
0  bed-days  and  63.1  DDD/100  bed-days,  respectively.
rial  consumption  was  D  7901.33  for  all  the  patients
ent)  and  D  6500.26  (D  29.01  per  infected  patient),
ould  follow  and  assess  their  antibiotic  use  expressed  in
r  antibiotic  use  with  national  and  international  hospitals
ziz  University  for  Health  Sciences.  Published  by  Elsevier
ethods
ospital setting
iyarbakir  Teaching  and  Research  Hospital  is  a  672
ed tertiary  center  with  six  intensive  care  units
ICUs), 10  medical  units  and  eight  surgical  units.
his center  ﬁrst  admitted  patients  in  2010,  and  it
erves as  a  referral  hospital  for  Turkey’s  southeast
egion.
For the  purposes  of  this  study,  data  were
ollected from  the  medical  (cardiology,  gastroen-
erology, nephrology,  internal  medicine,  infectious
iseases,  chest  diseases,  medical  oncology,  neu-
ology, dermatology  and  psychiatry)  and  surgical
general  surgery,  cardiovascular  surgery,  neuro-
urgery,  orthopedics,  otorhinolaryngology,  plastic
urgery, thoracic  surgery  and  urology)  departments
nd the  ICUs  (anesthesiology  and  reanimation,  neu-
osurgery,  thoracic  surgery,  chest  diseases,  general
urgery and  neurology).
A  cross-sectional  study  was  planned  to  com-
are the  periods  before  and  after  an  intervention.
ore speciﬁcally,  the  point  prevalence  method
as used  in  this  study.  Three  separate  teams,
ach consisting  of  an  infectious  diseases  special-
st and  an  infection  control  nurse,  underwent
raining, and  all  clinics  were  surveyed  by  these
eams from  May  16,  2011,  through  May  23,
012. All  patients  receiving  antimicrobial  treat-
ent were  included  in  the  study,  regardless  of
he indication.  Patient  ﬁles,  nursing  observation
ow sheets  and  physicians’  orders  from  each
linic were  individually  inspected  for  each  patient.
hen  necessary,  the  clinics’  physicians  and  nurses
ere also  consulted.  The  demographic  character-
stics, diagnoses,  drugs,  antimicrobial  drug  doses
nd dose  ranges,  microbiological  and  biochemi-
al test  results  and  radiological  imaging  ﬁndings
f each  patient  receiving  antimicrobial  treat-
ent were  recorded  on  a pre-designed,  standard
orm. Furthermore,  to  determine  the  duration  of
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ntimicrobial  treatment  in  the  patients  who  were
reated  for  prophylactic  purposes,  antibiotic  use  on
he previous  day  was  also  assessed.  Any  missing
ata were  completed  through  the  revision  of  the
atient  ﬁles  in  the  days  following  the  study.
The criteria  of  the  Centers  for  Disease  Control
CDC) and  the  methodology  of  the  National  Health-
are Safety  Network  (NHSN)  were  employed  for
he diagnosis  of  hospital-acquired  infections  (HAIs)
8].  Fever  of  unknown  origin  (FUO)  was  diagnosed
ccording to  the  criteria  described  by  Petersdorf
nd Beeson  [9]. Every  physician  evaluated  the
ppropriateness  of  antibiotic  use  in  the  clinics  that
/he inspected  according  to  the  criteria  speciﬁed  in
he Sanford  Guide  to  Antimicrobial  Therapy  [10].
The appropriateness  of  surgical  prophylactic
ntibiotherapy  was  evaluated  in  light  of  the  inter-
ational  guidelines  for  the  antibiotic  of  choice,  its
ose and  dose  interval,  the  time  and  duration  of  its
dministration  and  any  additional  doses  due  to  the
uration of  surgery  [11—13].
The guidelines  recommend  the  administration  of
 nontoxic  and  low-cost,  narrow-spectrum  antibi-
tic within  30—60  min  before  incision.  In  this
ontext, the  World  Health  Organization  (WHO)
egards cefazolin  and  cefuroxime  as  the  only
uitable antimicrobial  agents.  If  the  rates  of
ethicillin-resistant  Staphylococcus  epidermidis
r Staphylococcus  aureus  infections  are  known
r thought  to  be  high,  if  the  patient  has  a
ife-threatening  beta-lactam  allergy,  or  if  a  large-
cale surgery  involving  a  metal  prosthesis  is
lanned,  vancomycin  is recommended  as  the  antibi-
tic of  choice.  In  all  other  procedures,  ﬁrst-
r second-generation  cephalosporins  (cefazolin  or
efuroxime)  are  recommended  as  the  ﬁrst-line
ntibiotic. Moreover,  if blood  loss  during  surgery
xceeds 1500  ml  or  if  the  duration  of  surgery  is
onger than  240  min,  additional  doses  of  antibiotics
re recommended  [11—13].
The administered  antibiotic  treatments  were
lassiﬁed into  three  groups:  appropriate,  inappro-
riate  and  unnecessary.  Treatment  was  determined
o be  ‘inappropriate’  if  the  antimicrobial  agent  was
icrobiologically  or  pharmacologically  incorrect.
reatment was  judged  ‘unnecessary’  when  there
as no  clinical  or  laboratory  evidence  of  infection
r when  antibiotics  were  used  for  prophylaxis  with-
ut proper  indications.
Microbiologically  inappropriate  use  was  deﬁned
s the  use  of  antibiotics  without  a  justiﬁable  indi-
ation; the  choice  of  an  antibiotic  that  does  not
nclude the  infection-causing  agent  in  its  spectrum,
n unnecessarily  wide-spectrum  drug  or  a  reserve
rug that  was  administered  despite  the  availabil-
ty of  an  alternative  with  a  narrower  spectrum;
a
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r  the  use  of  a drug  as  part  of  an  unnecessary
ombination  treatment.  Pharmacologically  inap-
ropriate  use  was  deﬁned  as  the  administration
f antibiotics  at  inappropriate  doses  and  for  inap-
ropriate  durations  or  the  use  of  a  more  toxic
ntibiotic (having  greater  side  effects)  when  a  less-
oxic alternative  was  available.
The WHO  recommends  the  use  of  the  ATC/DDD
ndex (2010),  which  was  created  in  collaboration
ith the  Centre  for  Drug  Statistics  Methodology  for
he calculation  of  the  intensity  of  antibiotic  use  in
ospitals. The  ATC/DDD  index  provides  ATC  codes
nd DDD  values  for  each  substance  and/or  ATC  lev-
ls. The  WHO  recommends  the  application  of  the
TC classiﬁcation  system  and  the  DDD  measurement
nit in  drug  utilization  studies.  The  ATC  classiﬁca-
ion system  separates  drugs  into  groups  that  are
lassiﬁed  at ﬁve  different  levels.  The  1st  level
ivides the  drugs  into  14  main  groups.  The  2nd  level
ndicates  the  pharmacological  and  therapeutic  sub-
roups. The  3rd  and  4th  levels  include  the  chemical,
harmacological and  therapeutic  subgroups,  and
he 5th  level  is  the  chemical  substance.  In  cases
n which  the  pharmacological  subgroups  are  consid-
red to  be  more  appropriate  than  the  therapeutic
r chemical  subgroups,  the  2nd,  3rd  and  4th  lev-
ls are  often  used  to  identify  the  pharmacological
ubgroups  [14].
The  DDD  method  standardizes  the  calculation
f antibiotic  consumption  intensity  in  hospitals,
llowing comparisons  with  other  hospitals.  This
ssessment  helps  to  improve  the  quality  of  antimi-
robial  use.  The  DDD  assigned  by  the  WHO  is  the
ssumed  average  maintenance  dose  per  day  of  a
rug used  for  its  main  indication.  Deﬁnitions  of
DD are  updated  on  a  yearly  basis.  DDD  is  calcu-
ated by  dividing  the  total  amount  of  the  antibiotic
sed daily  for  every  procedure  by  the  DDD  coefﬁ-
ient of  that  antibiotic  in  the  ATC/DDD  system.  The
ecommended  standard  unit  for  measuring  antibi-
tic consumption  in  hospitals  is  deﬁned  as  the
DD per  100  bed-days,  which  is  also  referred  to
s the  Antimicrobial  Consumption  Index  (ACI)  [14].
he ACI  of  a hospital  is  calculated  by  dividing  the
otal (inpatient)  DDD  by  the  number  of  bed-days
nd multiplying  this  value  by  100.  The  result  is
xpressed  as  DDD/100  bed-days.  Quantifying  their
ntibiotic use  using  the  ACI  allows  hospitals  to  com-
are their  antibiotic  consumption  with  that  of  other
ospitals,  regardless  of  differences  in  the  formu-
ary composition,  antibiotic  potency  and  hospital
ensus  [4,14].
In  our  study,  the  DDDs  of  the  administered
ntimicrobial  agents  are  listed  according  to  the
TC/DDD  Index  2010  Group  ‘J01’  (antibiotics  for
ystemic  use)  [14].  The  costs  of  the  administered
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antimicrobials  were  calculated  based  on  the  daily
retail prices  in  Turkish  Liras  (TL).  The  total  cost  was
calculated  in  Euros  based  on  the  exchange  rate  in
Turkey. The  exchange  rate  for  Euros  in  2011  was
1D = 2.15  TL,  whereas  the  rate  was  1D  =  2.32  TL  in
2012.
Intervention
To  achieve  an  effective  intervention  and  maintain
good coordination  with  our  physicians,  the  Infec-
tion Control  Committee  held  a  series  of  meetings
with an  appointed  attending  physician  from  each
clinic.  During  these  meetings,  the  following  deci-
sions  were  made:  (1)  International  therapeutic  and
surgical prophylaxis  guidelines  shall  be  adopted  by
our hospital  and  will  be  used  to  promote  appro-
priate antibiotic  use.  (2)  To  administer  antibiotics
at the  right  time  point,  the  anesthesia  technician,
instead of  the  ward  nurse,  shall  be  responsible  for
the initial  prophylactic  antibiotic  dose.
All of  these  decisions  were  announced  to  all
physicians, and  regular  observations  were  per-
formed  for  1  year.  The  daily  clinic  visits  of  an
ICN were  accompanied  by  visits  by  a  responsi-
ble Infectious  Diseases  Control  Specialist  (IDCS)
twice per  week,  and  the  observation  results  were
shared  with  the  physicians  at  every  clinic.  The
frequency of  the  inspections  and  feedback  was
increased  in  the  clinics  in  which  compliance  with
the guidelines  was  observed  to  be  low.  Addition-
ally, the  responsible  IDCS  who  visited  the  ICUs
daily evaluated  ongoing  antibacterial  treatments
discontinued unnecessary  treatments  and  replaced
inappropriate  antibiotics  with  appropriate  agents.
This protocol  was  implemented  in  coordination  with
the physician  responsible  for  the  ICU  and  several
doctors working  in  the  ICU.  Additionally,  monthly
seminars were  held  to  educate  the  clinicians  about
the appropriate  use  of  antibiotics.
Following  the  1-year  intervention  period,  the
point prevalence  study  was  repeated,  and  the
newly  obtained  data  for  2012  were  compared  with
the pre-intervention  data  from  2011.  For  the  years
2011 and  2012,  the  ACI  and  DDD  values  and  the  costs
of antibiotic  consumption  were  individually  calcu-
lated for  the  medical  units,  surgical  units  and  ICUs,
as previously  described.  Furthermore,  the  ACI  and
DDD values  for  the  unnecessarily  and  inappropri-
ately used  antibiotics  were  calculated,  and  a cost
analysis  was  performed.
All  data  were  coded  and  entered  into  a  Microsoft
Excel ﬁle,  which  was  analyzed  using  the  SPSS
15.0 software  package.  In  the  statistical  analy-
sis of  the  data  obtained  before  and  after  the
intervention, ACI  values  were  assessed  using  the
a
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ann-Whitney  U-test.  Additionally,  the  Student’s
-test was  employed  for  cost  analysis,  and  the  Chi-
quare test  was  used  for  the  evaluation  of  antibiotic
onsumption.  A  value  of  p  <  0.05  was  accepted  as
tatistically  signiﬁcant.
esults
n  2011  and  2012,  a  total  of  719  patients  (307  and
12 patients,  respectively)  were  hospitalized,  and
94 of  307  (63.2%)  and  224  of  412  (54.4%),  respec-
ively,  received  antibiotic  treatment.  In  the  2  years,
he antibiotic  consumption  rates  in  the  wards  were
imilar. In  particular,  in  2011  and  2012,  the  antibi-
tic consumption  rates  were  respectively  54.1%  and
7.7% in  the  surgical  units,  64.8%  and  54%  in  the
nternal  medicine  units  and  85%  and  81.8%  in  the
CUs (p  =  0.397).  On  the  study  days,  none  of  the
atients  in  the  psychiatry,  dermatology  or  urology
linics  received  any  antibiotics.  In  2011,  the  mean
ge (±SD)  of  the  patients  was  49.9  ±  27.2  years,
nd men  accounted  for  53.1%  of  the  patients.  Sim-
larly, in  2012,  the  mean  age  (±SD)  of  the  patients
as 47.6  ±  17.4  years,  and  men  accounted  for  50.4%
f the  patients.  The  nosocomial  infection  (NI)  rates
ere 13.9%  and  11.2%  in  2011  and  2012  respectively.
he rates  of  antimicrobial  use  by  the  individual  clin-
cs in  2011  and  2012  and  the  related  indications  are
resented in  Table  1.
Tables  2  and  3  detail  the  indications  for  antimi-
robial treatment  in  2011  and  2012,  respectively,
ccording to  the  clinical  service  (medical,  surgi-
al or  intensive  care).  Appropriate  antibiotics  were
sed in  51%  and  63.4%  of  cases,  respectively.  Inap-
ropriate  antibiotics  use  was  more  prevalent  in  the
urgical units  than  in  the  medical  units  or  ICUs
p =  0.004  in  2011  and  p  = 0.009  in  2012).  The  route
f administration  of  antimicrobial  prophylaxis  was
ppropriate  in  all  of  the  procedures,  whereas  the
uration  was  optimal  in  only  10.3%  and  59.4%  of  the
atients in  2011  and  2012,  respectively.  The  mean
otal antibiotic  consumption  rate  was  93.6  DDD/100
ed-days  in  2011  and  63.1  DDD/100  bed-days  in
012, and  the  absolute  change  was  30.2  DDD/100
ed-days (p  =  0.008)  (Table  4).
During  the  study  period,  the  most  frequently
sed antibiotics  were  cephalosporin,  ﬂuoro-
uinolones, combinations  of  penicillin  (including
-lactamase inhibitors)  and  carbapenems  (Table  5).
owever, the  most  prominent  reduction  was
bserved in  the  consumption  of  glycopeptides
nd ﬂuoroquinolones  (absolute  change:  −6.3;
 =  0.162)  (Table  6).  The  most  frequently  misused
ntibiotics  in  both  years  were  cephalosporin,
uoroquinolones,  penicillin  (including  -lactamase
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Table  1  Rates  of  antibiotic  use  by  hospital  unit:  2011  and  2012.
Medical  units  Surgical  units  Intensive  care  units  Total  p
2011  2012  2011  2012  2011  2012  2011  2012
ET  95.7  98.1  48.5  50  55.9  77.8  72.7  77.2  0.397
MEBT  4.3 1.9 12.1 11  35.3  22.2  12.4  8.5
PT  —  —  39.4 39  8.8 —  14.9  14.3
ET: empirical treatment; MEB: microbiological evidence-based treatment; PT: prophylactic treatment.
Table  2  2011  and  2012:  evaluating  antibiotic  indications  by  hospital  units.
Medical  units  Surgical  units  Intensive  care  units
2011/2012(%)  2011/2012(%)  2011/2012(%)
A  U  I  A  U  I  A  U I
ET  54.4/63.4  20/15.4  25.6/21.2  43.8/56.1  21.8/17.1  34.4/26.8  73.7/75  10.5/10.7  15.8/14.3
MEB  75/100  —/—  25/—  75/77.8  12.5/11.1  12.5/11.1  83.4/87.5  8.3/—  8.3/12.5
PT  —/—  —/—  —/—  11.5/25  19.2/15.6  69.3/59.4  —/—  —/—  100/—
Total 55.3/64.2  20.2/15.1  24.5/20.7  34.8/46.3  19.7/15.9  45.5/37.8  70.6/77.8  8.8/8.3  20.6/13.9
A: appropriate; U: unnecessary; I: inappropriate; ET: empirical treatment; MEB: microbiological evidence-based treatment; PT:
prophylactic treatment.
Table  3  Evaluating  of  treatments  according  to  indications  of  total  usage  in  2011  and  2012.
2011(%)  2012(%)  p
A  U  I  A  U  I
ET  54.6  19.1  26.3  63.6  15  21.4
MEB  79.2  12.5  8.3  84.2  5.3  10.5  0.023
PT  10.3  17.2  72.5  56.3  6.2  37.5
Total 51  18  31  64.3  12.9  22.8
A: appropriate; U: unnecessary; I: inappropriate; ET: empirical treatment; MEB: microbiological evidence-based treatment; PT:
prophylactic treatment.
Table  4  Total  antibiotic  consumption  by  class:  2011  and  2012.
Antiinfectives  group  ATC  code  ACIa Absolute  change  (%)  Percentage  of
total  use
2011  2012  2011—2012  2011  2012
Combination  of  penicillins
Including  -lactamase JO1CR  14.4  10.1  −4  (−28.3)  15.39  16
Cephalosporins,  ﬁrst-generation  JO1DB  6.1  6  −0.1  (−1.63)  6.52  9.5
Cephalosporins,  third-generation  JO1DD  12.7  7.7  −5  (−39.3)  13.56  12.3
Carbapenems  JO1DH  12  9.2  −2.8  (−23.3)  12.82  14.58
Aminoglycosides  JO1GB  1.2  1.2  0  (0)  1.29  1.9
Fluoroquinolones  JO1MA  16.4  10.5  −5.9  (−35.9)  17.52  16.64
Glycopeptides  JO1XA  14  7.7  −6.3  (−45)  14.96  12.3
Lınezolıds  JO1XX  8.3  5.3  −3  (−36.1)  8.86  8.39
Polymyxins  JO1XB  4  2.5  −1.5  (−37.5)  4.28  3.97
Tigecycline  JO1AA  4.5  2.9  −1.6  (−35.5)  4.8  4.6
Total 93.6  63.1  −30.2  100  100a ACI: antimicrobial consumption index (DDD per 100 bed-days).
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Table  5  DDD  and  ACIa by  class  and  clinical  unit:  2011  and  2012.
Antiinfectives  group  Medical  units  Surgical  units  Intensive  care  units
2011  2012  2011  2012  2011  2012
DDDs  ACI  DDDs  ACI  DDDs  ACI  DDDs  ACI  DDDs  ACI  DDDs  ACI
Combination  of  penicillins
Including  -lactamase  19  13.4  22  11.2  24  19.6  18  10.4  1.5  3.7  2  4.5
Cephalosporins  34  23.4  25  12.7  19  15.5  25  14.5  5  12.5  7  15.9
Carbapenems  11  7.5  10  5.1  18  14.7  18  10.4  8  20  10  22.7
Aminoglycosides  1.3  0.9  2  1  1.3  1  2  1.1  1.3  3.2  1.3  3
Fluoroquinolones  16  11  17.6  8.9  23.6  19.3  16.8  9.7  10.8  27  9.2  20.9
Glycopeptides  18  12.4 11  5.6 15  12.2  12  6.9  10  25  9  20.4
Lınezolıds  7.5 5.1 10  5.1 12  9.8 9 5.2  6  15  3  6.8
Polymyxins  2.5  1.7  2.5  1.2  5  4  5  2.9  5  12.5  3  6.8
Tigecycline  2  1.3  2  1  8  6.5  4  2.3  4  10  6  13.6
Total  113.3  76.7  102.1  51.8  127.9  102.6  109.8  63  51.6  128.9  50.5  114.6
a ACI: antimicrobial consumption index (DDD per 100 bed-days).
Table  6  Inappropriate/unnecessary  antibiotics  by  class:  2011  and  2012.
Antiinfectives  group ATC  code ACIa Absolute  change  (%) Percentage  of
total  use
2011  2012  2011—2012  2011  2012
Combination  of  penicillins
Including  -lactamase  JO1CR  5.8  2.9  −2.9  (−50)  23.48  21.32
Cephalosporins,  ﬁrst-generation  JO1DB  2  1  −1  (−50)  8.09  7.35
Cephalosporins,  third-generation  JO1DD  4.2  2.1  −1  (−50)  17  15.44
Carbapenems  JO1DH  3.4  2.1  −1.3  (−38.2)  13.76  15.44
Aminoglycosides  JO1GB  0.6  0.3  −1  (−50)  2.43  2.3
Fluoroquinolones  JO1MA  6.5  3.8  −2.7  (−41.5)  26.32  27.94
Glycopeptides  JO1XA  1.3  0.7  −0.6  (−46.1)  5.27  5.15
Lınezolıds  JO1XX  0.9  0.7  −0.2  (−22.2)  3.65  5.15
Total  24.7  13.6  −9.7  100  100
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Da ACI: antimicrobial consumption index (DDD per 100 bed-d
inhibitors)  and  carbapenems  (Table  6).  When  our
hospital’s  unnecessary  antibiotic  consumption  lev-
els in  2011  and  2012  were  compared,  we  observed
reductions in  two  classes:  penicillin  (speciﬁcally,
-lactam inhibitor  combinations)  and  ﬂuoro-
quinolones. The  absolute  reductions  observed
were 2.9%  and  2.7%,  respectively  (p  =  0.247).  When
the consumption  rates  of  individual  services  were
compared,  we  found  the  highest  levels  in  surgery
and the  ICUs,  followed  by  the  surgical  and  medical
units.
In the  2011  and  2012  study  periods,  the  daily
cost of  all  of  the  administered  antibacterial  agents
was D  7901.3  (D  40.7  per  infected  patient)  and
D 6500.3  (D  29  per  infected  patient),  respectively
(p < 0.001).  Compared  with  2011,  the  total  cost  of
antibiotics  in  the  medical  units,  surgical  units  and
ICUs in  2012  decreased  by  32.5%,  38.6%  and  11.1%,
T
t
uespectively.  The  daily  cost  of  all  analyzed  antibi-
tics was  respectively  D  2733.7  (D  29.1  per  infected
atient) and  D  2378.3  (D  22.4  per  infected  patient)
n the  medical  units,  D  2940.7  (D  44.6  per  infected
atient) and  D  2218.7  (D  27.1  per  infected  patient)
n the  surgical  units  and  D  2226.9  (D  65.5  per
nfected patient)  and  D  1903.2  (D  52.9  per  infected)
n the  ICUs.  In  2011  and  2012,  the  daily  cost  of
nnecessary  antibiotic  use  alone  was  D  1204.7  (D
.2 per  infected  patient)  and  D  1127.5  (D  5  per
nfected patient),  respectively  (p  <  0.001).
iscussiono  the  best  of  our  knowledge,  this  is  the  ﬁrst  study
o compare  pre-  and  post-interventional  periods
sing the  ATC/DDD  method  to  improve  antibiotic
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dnalysis  of  antimicrobial  consumption  and  cost  in  a
se  in  a  newly  established  teaching  and  research
ospital in  Turkey.
The point  prevalence  survey  (PPS)  is  a  practi-
al surveillance  tool  that  can  be  used  to  monitor
ntibiotic use  across  hospital  units  and  practition-
rs. Local  data  can  then  be  compared  with  data
rom  national  and  international  hospitals  to  iden-
ify the  outliers  and  to  plan  corrective  action
4,15].  When  our  hospital’s  antibiotic  consumption
n 2011  was  compared  with  that  of  national  and
nternational hospitals,  our  hospital’s  consumption
as determined  to  be  excessive  and  inappropri-
te. Additionally,  the  rate  of  inappropriate  surgical
rophylaxis  was  higher  than  in  other  hospitals
4,15—18].  This  ﬁnding  led  us  to  plan  an  interven-
ion to  promote  the  appropriate  use  of  therapeutic
ntibiotics and  antibiotics  for  perioperative  prophy-
axis.
The ATC/DDD  system  is  already  widely  used
nternationally,  and  its  use  is  constantly  increasing.
he DDD  has  been  used  to  compare  hospitals  and
ountries,  and  the  ACI  has  been  used  to  compare
oth inpatient  and  outpatient  antibiotic  use  in  the
nternational  setting  [14]. The  antibiotic  consump-
ion rate  of  our  hospital  was  found  to  be  higher  than
hat of  most  other  national  (36—53%)  [4,16]  and
uropean  (14—32%)  [17]  hospitals.  In  a multicen-
er study  conducted  in  Europe,  the  PPS  indicated
CI values  between  31.2  and  72.2  [18], whereas  the
PS in  a  multicenter  study  performed  in  Turkey  [15]
evealed  ACI  values  between  42.1  and  100.7.  The
CI values  of  our  hospital  in  2011  were  much  higher
han the  values  reported  in  Europe  but  were  close
o the  upper  limits  reported  in  Turkey.
This  ﬁnding  might  be  explained  by  the  tendency
f inexperienced  staff  to  prescribe  unnecessary
ntibiotics with  longer  courses  of  treatment.  When
he staff  was  asked  to  justify  such  practices,  chal-
enging  working  conditions  were  often  cited.  Data
btained  from  our  initial  PPS  allowed  us  to  design
n educational  intervention.  In  addition  to  monthly
eminars  that  broadly  focused  on  hand  hygiene  and
ther measures  to  prevent  HAIs,  antibiotic  overuse
as also  addressed,  with  targeted  reviews  of  pre-
cribing  habits  and  systematic  feedback  provided
o physicians  [19,20].  Following  these  interven-
ions, the  PPS  conducted  in  2012  found  that  the
CI values  for  all  classes  of  antibiotics  decreased  by
2.6% (from  93.6%  to  63.1%).  Unnecessary  antibi-
tic use  also  declined  from  24.7%  to  13.6%,  with
 decrease  of  44.9%,  and  the  rate  of  NI  fell  by
9.4%, from  13.9%  to  11.2%.  Although  this  initia-
ive achieved  several  goals,  further  interventions
ill be  necessary  to  improve  guideline  compliance
nd to  ensure  continued  reductions  in  antibiotic
se.
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Studies  have  reported  that  10.7—30%  of  pre-
cribed antibiotics  are  unnecessary  [1,21]. When
nappropriate  use  of  antibiotics  is  also  taken
nto consideration,  this  value  rises  to  28—63%
4,21—23]. In  Turkey,  30—53%  of  the  hospitalized
atients are  prescribed  antibiotics,  and  30—68%  of
hese prescriptions  are  reported  to  be  inappro-
riate. At  our  hospital,  the  rates  of  unnecessary
ntibiotic use  were  18%  and  14.3%  in  2011  and  2012,
espectively.  When  inappropriate  use  of  antibi-
tics was  added,  these  rates  increased  to  49%  and
0.2%, respectively.  These  values  are  consistent
ith reports  in  the  literature  [4,21—23].
A multicenter  study  performed  by  Bailly  et  al.
ndicated  that  58.3%  of  all  perioperative  antimicro-
ial prophylaxes  are  inappropriate  [24]. In  2011  and
012, inappropriate  antibiotic  use  was  signiﬁcantly
igher in  surgical  clinics  than  in  internal  medicine
linics and  ICUs.  This  discrepancy  was  largely  due
o the  high  level  of  inappropriate  antibiotics  that
ere administered  to  prevent  perioperative  infec-
ions. Our  hospital  is  not  exceptional  in  this  regard.
t is  estimated  that  one-third  of  all  antibiotics  con-
umed globally  are  prescribed  for  this  reason.  Other
eports identiﬁed  perioperative  prophylaxis  as  the
eason for  the  high  levels  of  inappropriate  antibi-
tics consumed  by  inpatients.  Published  reports
lso emphasized  that  the  majority  of irrational
ntibiotic prescriptions  in  surgery  departments  are
ue to  inappropriate  prophylaxis  [25—27].
During both  study  periods,  approximately  one-
hird of  the  indications  for  antibiotic  use  in
ur surgical  clinics  were  perioperative  prophylaxis
39.4% in  2011  and  39%  in  2012),  and  88.5%  to  43.7%
f the  antibiotic  prescriptions  for  this  indication
n 2011  and  2012  respectively,  were  inappropri-
te and  unnecessary.  In  another  multicenter  study
onducted  in  Turkey,  Hosoglu  et  al.  observed  that
8% of  surgeons  prescribed  more  than  one  dose  of
ntibiotics  and  that  32%  chose  the  wrong  antibi-
tic agent  [28]. The  most  important  cause  of
uch inappropriate  perioperative  prophylaxis  was
 long  duration  of  antibiotic  treatment  [29,30].
n our  country,  there  are  no  established  national
uidelines for  surgical  prophylaxis,  although  certain
ospitals conform  to  their  local  guidelines.
To improve  compliance  with  international  guide-
ines for  perioperative  antimicrobial  prophylaxis  in
ur hospital,  we  tried  to  create  synergy  through
ducational seminars,  observations,  feedback  and
requent meetings.  Consequently,  inappropriate
urations of  perioperative  antimicrobial  prophy-
axis fell  from  89.7%  (26  of  29  patients  administered
erioperative antimicrobial  prophylaxis)  in  2011  to
0.6% (13  of  32  patients  administered  perioperative
ntimicrobial prophylaxis)  in  2012.
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The  antibiotic  consumption  rates  in  Turkey  are
higher  than  in  many  European  countries,  including
Sweden, Denmark,  Germany  and  Hungary  [31].  In
the ARPAC  Project,  the  majority  of  the  antibiotics
used in  all  hospitals  were  found  to  be  penicillin
beta-lactams,  followed  by  non-penicillin  beta-
lactams and  quinolones  [32].  In  our  study,  the  most
frequently  used  antibiotics  were  cephalosporin,  fol-
lowed by  ﬂuoroquinolones,  penicillins  (including
beta-lactam inhibitors)  and  carbapenems.  These
groups of  antibiotics  were  also  the  most  frequently
misused at  our  hospital.  In  another  study  conducted
in a  university  hospital  in  Turkey,  the  most  com-
monly used  classes  of  antibiotics  were  found  to  be
cephalosporins,  penicillins  (including  beta-lactam
inhibitors) and  carbapenems  [6]. Our  study  yielded
similar  results.  In  the  previous  study,  daily  antibi-
otic costs  per  infected  patient  ranged  from  D  25.4
to 29.9.  Our  intervention  also  successfully  reduced
the per-person  costs  to  this  range,  as  a  reduction
of 28.8%  (from  D  40.7  prior  to  the  intervention  to  D
29 at  the  conclusion  of  our  study)  was  achieved.
Conclusion
When  daily  monitoring  of  antibiotic  use  is  not  prac-
tical, hospitals  should  routinely  conduct  PPSs  to
ensure the  appropriateness  of  antibiotic  prescrip-
tions strategies.  Additionally,  these  hospitals  should
use the  DDD  and  ACI  calculations  to  standardize
and compare  their  antibiotic  use  with  that  of  both
national  and  international  hospitals.
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